Interim Leadership
- For clinical-stage biotech leaders who do not have FTEs dedicated to market access & pricing and who need senior functional input in their commercial strategy
- For commercial-stage pharma or medtech leaders who are faced with a temporary leadership vacancy in the market access & pricing function
You benefit from a senior leader who can provide the strategic input you need in the organization
Contingent Staffing
- Company leaders facing an urgent and important milestone or decision point who need the extra resource to provide market access & pricing input into the asset strategy
- When a key project or program has accelerated and you need an extra resource to develop the commercial strategy
We provide the temporary resource to fill the gap and successfully complete the project
Project Execution
- When you quickly need to generate actionable insights to feed into your commercial strategy:
- Organize a payer advisory board
- Run a literature review,
- Perform a market access & pricing landscape assessment, …
We translate actionable insights into strategic imperatives for your brands
Opportunity Assessment
M&A or licensing deal are typically associated with short deadlines to characterize the commercial landscape, the product’s evidence package, or provide a full commercial valuation of the opportunity
We provide the expertise in business development across multiple TAs. We provide input in scenario analyses on the impact of potential future policy changes
Governance & processes
As companies evolve in preparation of their first commercial launch or for a market expansion, they need to adapt their structure & processes to remain agile while incorporating additional functions, expertise or geographies
We guide you in setting up organizational structure, pricing governance, processes & IT systems for the commercial launch of new products & indications
L-MAPS™
L-MAPS™ is a user-friendly tool to assess the value and the likelihood of success of an asset, or portfolio of assets, from a payer perspective. The results from L-MAPS™ feed into brand planning and strategy reviews, product valuation, financial forecasting, clinical development and evidence generation plans. Please reach out to find out how L-MAPS™ can solve your challenges.
We provide the L-MAPS™ tool for cross-functional teams to make better decisions about early development assets or portfolios
INVESTOR-MACS™
A flexible investment approach designed for clinical-stage / small biotech*
- When … you need a strategic advisor and investor at your side, more than an outside consultant
- What … you determine the proportion of the consulting budget that is converted in shares/stocks of your company
- Why?
- Minimize the impact on your cash flow
- Hire an advisor with vested interests in your company’s success
- Gain a long-term commitment from a senior advisor
- Exclusive commitment within the specific indication
* Companies with market cap. < $1Bn; further conditions may apply, please enquire at info@iPATH-solutions.com